inactivated poliomyelitis vaccine
PolandDrugs containing this active substance
-
The vaccine is used to prevent poliomyelitis (polio) in infants, children, adolescents, and adults. It may be used as part of a primary vaccination schedule or as a booster dose.
Form: solution for injection in ampoule-syringe
Active substance Dosage poliovirus type 1 mahoney strain inactivated 29 units of antigen D inactivated poliomyelitis vaccine 0.5 ml poliovirus type 2 mef-1 strain inactivated 7 units of antigen D poliovirus type 3 sabin strain inactivated 26 units of antigen D ATC: J07BF03
Manufacturer: Sanofi Winthrop Industry Sanofi Winthrop Industry Sanofi-Aventis Ltd.